Director reports multiple Class A share sales — RXRX (NASDAQ: RXRX)
Rhea-AI Filing Summary
RXRX filed a Form 144 reporting proposed sales of Class A founder shares.
The filing lists four sales of 40,000 Class A shares on 01/05/2026, 01/20/2026, 02/04/2026, and 02/19/2026 with proceeds of $170,000, $178,800, $164,800, and $138,400, respectively.
Positive
- None.
Negative
- None.
Insights
Form 144 lists four discrete sales of Class A founder shares totaling 160,000 shares across January–February 2026.
The filing identifies four transactions of 40,000 Class A shares each on 01/05/2026, 01/20/2026, 02/04/2026, and 02/19/2026, with reported gross proceeds per trade shown in the filing.
These notices are procedural disclosures required under rule 144; cash‑flow treatment and whether sales were open‑market or private are not stated in the provided excerpt.
FAQ
What did RXRX report in this Form 144?
Who is the reported seller in the RXRX Form 144?
How many shares are involved in the RXRX filing?
Do the Form 144 entries state how the shares were sold?